More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases

Scandinavian Journal of Rheumatology

Volumn 39, Issue 6, 2010, Pages 461-465

  Vasala, M ^a   Immonen, K ^b   Kautiainen, H ^c   Hakala, M ^c,d,e  

^a Departments of Medicine   (Finland)

^b NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^c RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CREATININE;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AMYLOIDOSIS; ARTICLE; COLONOSCOPY; CREATININE BLOOD LEVEL; DEATH; DIAGNOSTIC ACCURACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROSCOPY; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RECTUM BIOPSY; RHEUMATIC DISEASE; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; ANTIRHEUMATIC AGENTS; BLOOD SEDIMENTATION; CREATININE; FEMALE; FINLAND; HUMANS; INCIDENCE; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; METHOTREXATE; MIDDLE AGED; PREVALENCE; PROTEINURIA; RECTUM; RHEUMATIC DISEASES; SUBCUTANEOUS FAT, ABDOMINAL; YOUNG ADULT;

EID: 78649700306     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009741003747481     Document Type: Article

References (29)

1. Filipowicz-Sosnowska AM, Rostopowicz-Denisiewicz K, Rosenthal CJ, Baum J. The amyloidosis of juvenile rheumatoid arthritis - comparative studies in Polish and American children. I. Levels of serum SAA protein. Arthritis Rheum 1978;21:699-703.
2. Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44-9.
3. Kvalvik AG. Mortality in rheumatoid arthritis. Rheumatol Eur 1996;25:9-14.
4. Wiland P, Wojtala R, Goodacre J, Szechinski J. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis. Clin Rheumatol 2004;23:193-8.
5. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomaki H. Shortening of life span and causes of excess mortality in a population based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149-53.
6. Myllykangas-Luosujarvi R, Aho K, Lehtinen K, Kautiainen H, Hakala M. Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol 1998;37:688-90.
7. Savolainen HA, Isomaki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201-3.
8. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-6.
9. Hazenberg B P C, van Rijswijk MH. Where has secondary amyloidosis gone? Ann Rheum Dis 2000;59:577-9.
10. Marsik C, Endler G, Gulesserian T, Wagner OF, Sunder-Plassmann G. Classification of chronic kidney disease by estimated glomerular filtration rate. Eur J Clin Invest 2008;38:253-9.
11. Klemi PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol 1987;16:429-31.
12. Dhillon V, Woo P, Isenberg D. Amyloidosis in the rheumatic diseases. Ann Rheum Dis 1989;48:696-701.
13. Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18:122-3.
14. Kaipiainen-Seppanen O, Myllykangas-Luosujarvi R, Lampainen E, Ikaheimo R. Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis. Scand J Rheumatol 2000;29:232-5.
15. Immonen K, Savolainen A, Kautiainen H, Hakala M. Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland? Scand J Rheumatol 2007;36:402-3.
16. Finnish Registry for Kidney Diseases. Available from: www.musili.fi/fin/munuaistautirekisteri/finnish-registry-for-kidney-diseases
17. Finne P, Reunanen A, Stenman S, Groop P-H, Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. J Am Med Assoc 2005;14:1782-7.
18. Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a populationbased cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993;20:1674-8.
19. Husby G. Amyloidosis in ankylosing spondylitis. Scand J Rheumatol 1980;32(Suppl): 67-70.
20. Hazenberg B P C, Limburg PC, Bijzet J, van Rijwijk MH. Factors influencing onset of amyloidosis and final outcome in patients with rheumatoid arthritis. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, editors. Amyloid and amyloidosis 1993. New York: Parthenon Publishing, 1994:700-2.
21. Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Gronhagen-Riska C. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases - data from the Finnish national registry for kidney diseases. J Rheumatol 2008;35:1334-8.
22. Klaukka T, Kaarela K. Methotrexate is the leading DMARD in Finland. Ann Rheum Dis 2003;62:494-6.
23. Falck HM, Maury C P J, Teppo A-M, Wegelius O. Correlation of persistently high serum amyloid A and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983;286:1391-3.
24. Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomaki H. Amyloidosis - incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 1993;22:158-61. (Pubitemid 23233550)
25. Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:107-14.
26. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
27. Peters MJ, van der Horst-Pruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.
28. Gertz MA. Secondary systemic amyloidosis. Response and survival in 64 patients. Medicine 1991;70:246-56.
29. Lachmann HJ, Goodman H J B, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic amyloidosis. N Engl J Med 2007;356:2361-71.